TROP2 is highly expressed in triple-negative breast cancer CTCs and is a potential marker for epithelial mesenchymal CTCs
2024 · Molecular Therapy Oncology · 23 citations
https://doi.org/10.1016/j.omton.2024.200762
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
41
Citations
2
h-index
2
i10-index
Zuli Ou is an academic researcher from Children's Hospital of Chongqing Medical University. The author has contributed to research in topics: Cancer, Hypoxia, and Metabolism & ATP Synthase and ATPases Research & Mitochondrial Function and Pathology. The author has an h-index of 2, co-authored 4 publications.
https://doi.org/10.1016/j.omton.2024.200762
https://doi.org/10.1016/j.phrs.2025.108081
Click to start Chat